16th Nov 2023 Plain language summary of the EMPEROR-Preserved : drug treatment with empagliflozin was beneficial in people with heart failure with preserved ejection fraction
15th Nov 2023 A plain language summary of the EMPEROR-Reduced study: drug treatment with empagliflozin lowered risk for hospitalization in people with heart failure with reduced ejection fraction